Repligen Statistics
Total Valuation
Repligen has a market cap or net worth of $11.39 billion. The enterprise value is $11.22 billion.
| Market Cap | 11.39B |
| Enterprise Value | 11.22B |
Important Dates
The last earnings date was Tuesday, October 27, 2026, before market open.
| Earnings Date | Oct 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Repligen has 63.92 million shares outstanding. The number of shares has increased by 0.43% in one year.
| Current Share Class | 63.92M |
| Shares Outstanding | 63.92M |
| Shares Change (YoY) | +0.43% |
| Shares Change (QoQ) | -0.14% |
| Owned by Insiders (%) | 0.28% |
| Owned by Institutions (%) | 109.35% |
| Float | 60.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 72.93 |
| PS Ratio | 14.14 |
| Forward PS | 11.10 |
| PB Ratio | 4.83 |
| P/TBV Ratio | 16.60 |
| P/FCF Ratio | 106.74 |
| P/OCF Ratio | 87.72 |
| PEG Ratio | 3.00 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 78.19, with an EV/FCF ratio of 105.14.
| EV / Earnings | n/a |
| EV / Sales | 13.93 |
| EV / EBITDA | 78.19 |
| EV / EBIT | 171.05 |
| EV / FCF | 105.14 |
Financial Position
The company has a current ratio of 9.88, with a Debt / Equity ratio of 0.33.
| Current Ratio | 9.88 |
| Quick Ratio | 8.07 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | 3.55 |
| Debt / FCF | 6.49 |
| Interest Coverage | 2.72 |
Financial Efficiency
Return on equity (ROE) is -0.57% and return on invested capital (ROIC) is -4.81%.
| Return on Equity (ROE) | -0.57% |
| Return on Assets (ROA) | 1.40% |
| Return on Invested Capital (ROIC) | -4.81% |
| Return on Capital Employed (ROCE) | 2.34% |
| Weighted Average Cost of Capital (WACC) | 9.31% |
| Revenue Per Employee | $402,805 |
| Profits Per Employee | -$5,902 |
| Employee Count | 2,000 |
| Asset Turnover | 0.28 |
| Inventory Turnover | 2.17 |
Taxes
In the past 12 months, Repligen has paid $20.03 million in taxes.
| Income Tax | 20.03M |
| Effective Tax Rate | 243.43% |
Stock Price Statistics
The stock price has increased by +18.67% in the last 52 weeks. The beta is 1.08, so Repligen's price volatility has been similar to the market average.
| Beta (5Y) | 1.08 |
| 52-Week Price Change | +18.67% |
| 50-Day Moving Average | 177.75 |
| 200-Day Moving Average | 144.97 |
| Relative Strength Index (RSI) | 49.98 |
| Average Volume (20 Days) | 1,342,268 |
Short Selling Information
The latest short interest is 7.15 million, so 11.18% of the outstanding shares have been sold short.
| Short Interest | 7.15M |
| Short Previous Month | 7.58M |
| Short % of Shares Out | 11.18% |
| Short % of Float | 11.72% |
| Short Ratio (days to cover) | 5.48 |
Income Statement
In the last 12 months, Repligen had revenue of $805.61 million and -$11.80 million in losses. Loss per share was -$0.21.
| Revenue | 805.61M |
| Gross Profit | 433.14M |
| Operating Income | 65.60M |
| Pretax Income | 8.23M |
| Net Income | -11.80M |
| EBITDA | 143.50M |
| EBIT | 65.60M |
| Loss Per Share | -$0.21 |
Balance Sheet
The company has $862.98 million in cash and $692.24 million in debt, with a net cash position of $170.74 million or $2.67 per share.
| Cash & Cash Equivalents | 862.98M |
| Total Debt | 692.24M |
| Net Cash | 170.74M |
| Net Cash Per Share | $2.67 |
| Equity (Book Value) | 2.09B |
| Book Value Per Share | 36.90 |
| Working Capital | 1.12B |
Cash Flow
In the last 12 months, operating cash flow was $129.86 million and capital expenditures -$23.15 million, giving a free cash flow of $106.72 million.
| Operating Cash Flow | 129.86M |
| Capital Expenditures | -23.15M |
| Depreciation & Amortization | 77.90M |
| Net Borrowing | n/a |
| Free Cash Flow | 106.72M |
| FCF Per Share | $1.67 |
Margins
Gross margin is 53.77%, with operating and profit margins of 8.14% and -1.47%.
| Gross Margin | 53.77% |
| Operating Margin | 8.14% |
| Pretax Margin | 1.02% |
| Profit Margin | -1.47% |
| EBITDA Margin | 17.81% |
| EBIT Margin | 8.14% |
| FCF Margin | 13.25% |
Dividends & Yields
Repligen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.43% |
| Shareholder Yield | -0.43% |
| Earnings Yield | -0.12% |
| FCF Yield | 0.94% |
Analyst Forecast
The average price target for Repligen is $203.45, which is 14.17% higher than the current price. The consensus rating is "Buy".
| Price Target | $203.45 |
| Price Target Difference | 14.17% |
| Analyst Consensus | Buy |
| Analyst Count | 21 |
| Revenue Growth Forecast (3Y) | 18.95% |
| EPS Growth Forecast (3Y) | 26.28% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Repligen has an Altman Z-Score of 6.92 and a Piotroski F-Score of 6.
| Altman Z-Score | 6.92 |
| Piotroski F-Score | 6 |